FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Akt
Open accessAbstract
Akt is a central regulator of cell growth. Its activity can be negatively regulated by the phosphatase PHLPP that specifically dephosphorylates the hydrophobic motif of Akt (Ser473 in Akt1). However, how PHLPP is targeted to Akt is not clear. Here we show that FKBP51 (FK506-binding protein 51) acts as a scaffolding protein for Akt and PHLPP and promotes dephosphorylation of Akt. Furthermore, FKBP51 is downregulated in pancreatic cancer tissue samples and several cancer cell lines. Decreased FKBP51 expression in cancer cells results in hyperphosphorylation of Akt and decreased cell death following genotoxic stress. Overall, our findings identify FKBP51 as a negative regulator of the Akt pathway, with potentially important implications for cancer etiology and response to chemotherapy.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
FKBP51 expression is decreased in several cancer cell lines and in pancreatic cancer tissue, and may correlate with increased Akt phosphorylation and reduced cell sensitivity to chemotherapeutic agents.
“FKBP51 expression is decreased in several cancer cell lines and in pancreatic cancer tissue, and may correlate with increased Akt phosphorylation and reduced cell sensitivity to chemotherapeutic agents.”
From FKBP51 and FKBP52 in signaling and disease (2011) · cites this paper as [50]
FKBP51 negatively regulates the activity of Akt by serving as a scaffolding protein to recruit the phosphatase PHLPP.
“A major advance in mechanistic understanding was the discovery that FKBP51 negatively regulates the activity of the cell growth regulator Akt, by serving as a scaffolding protein to recruit the phosphatase PHLPP [50].”
From FKBP51 and FKBP52 in signaling and disease (2011) · cites this paper as [50]
FKBP51 and FKBP52 likely have a similar activity to Pin1, but unlike Pin1, the FKBPs likely coordinate with Hsp90 to isomerize tau.
“FKBP51 and FKBP52 likely have a similar activity; however, unlike Pin1, the FKBPs likely coordinate with Hsp90 to isomerize tau [50].”
From FKBP51 and FKBP52 in signaling and disease (2011) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 6,535 · see citing works
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216 · see citing works
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115 · see citing works
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689 · see citing works
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · see citing works
Alessi, D., James, S., Downes, C., Holmes, A. B., Gaffney, P., Reese, C., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 3,047 · see citing works
Mechanism of activation of protein kinase B by insulin and IGF‐1.
Alessi, D. R., Andjelković, M., Caudwell, B., Cron, P. D., MORRICE, N. A., Cohen, P., & Hemmings, B. A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01045.x · Cited by 2,985 · see citing works
Interleukin-3-Induced Phosphorylation of BAD Through the Protein Kinase Akt
del Peso, L., González‐García, M., Page, C., Herrera, R., & Núñez, G. (1997) · Science · doi:10.1126/science.278.5338.687 · Cited by 2,213 · see citing works
A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase
Harding, M. W., Gałat, A., Uehling, D., & Schreiber, S. L. (1989) · Nature · doi:10.1038/341758a0 · Cited by 1,400 · see citing works
Mayo, L. D., & Donner, D. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181181198 · Cited by 1,230 · see citing works
Ten years of protein kinase B signalling: a hard Akt to follow
Brazil, D. P., & Hemmings, B. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01958-2 · Cited by 1,177 · see citing works
Biggs, W., Meisenhelder, J., Hunter, T. R., Cavenee, W. K., & Arden, K. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7421 · Cited by 1,116 · see citing works
Direct control of the Forkhead transcription factor AFX by protein kinase B
Kops, G. J. P. L., de Ruiter, N. D., de Vries-Smits, A. M. M., Powell, D. R., Bos, J. L., & Burgering, B. M. T. (1999) · Nature · doi:10.1038/19328 · Cited by 1,085 · see citing works
A physical and functional map of the human TNF-α/NF-κB signal transduction pathway
Bouwmeester, T., Bauch, A., Ruffner, H., Angrand, P., Bergamini, G., Croughton, K., Cruciat, C., Eberhard, D., Gagneur, J., Ghidelli, S., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1086 · Cited by 1,030 · see citing works
HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation
Zhou, B. P., Liao, Y., Xia, W., Zou, Y., Spohn, B., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-973 · Cited by 951 · see citing works
Gao, T., Furnari, F., & Newton, A. C. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.008 · Cited by 906 · see citing works
Maurer, U., Charvet, C., Wagman, A. S., Dejardin, E., & Green, D. R. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.02.009 · Cited by 881 · see citing works
Phosphorylation of the Transcription Factor Forkhead Family Member FKHR by Protein Kinase B*
Rena, G., Guo, S., Cichy, S. C., Unterman, T., & Cohen, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17179 · Cited by 787 · see citing works
Brognard, J., Sierecki, E., Gao, T., & Newton, A. C. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.017 · Cited by 591 · see citing works
Activation of the PI3K/Akt pathway and chemotherapeutic resistance
West, K. A., Castillo, S. S., & Dennis, P. A. (2002) · Drug Resistance Updates · doi:10.1016/s1368-7646(02)00120-6 · Cited by 583 · see citing works
Rheb Activates mTOR by Antagonizing Its Endogenous Inhibitor, FKBP38
Bai, X., Ma, D., Liu, A., Shen, X., Wang, Q. J., Liu, Y., & Jiang, Y. (2007) · Science · doi:10.1126/science.1147379 · Cited by 382 · see citing works
The Phosphatase PHLPP Controls the Cellular Levels of Protein Kinase C
Gao, T., Brognard, J., & Newton, A. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707319200 · Cited by 211 · see citing works
Molecular chaperone interactions with steroid receptors: an update.
Cheung, J., & Smith, D. F. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.7.0489 · Cited by 198 · see citing works
Barent, R. L., Nair, S. C., Carr, D. C., Ruan, Y., Rimerman, R. A., Fulton, J., Zhang, Y., & Smith, D. F. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.3.0075 · Cited by 190 · cited 2× · see citing works
“However, overexpression of the FKBP51 mutant FD67/68DV, which lacks peptidylprolyl isomerase activity (Barent et al., 1998), had similar effect on Akt Ser473 phosphorylation as wild-type (WT) FKBP51 (Figure S3A), suggesting that FKBP51 regulates Akt phosphorylation in a peptidylprolyl isomerase-independent manner.”
Gemcitabine and Cytosine Arabinoside Cytotoxicity: Association with Lymphoblastoid Cell Expression
Li, L., Fridley, B. L., Kalari, K. R., Jenkins, G. D., Batzler, A. J., Safgren, S. L., Hildebrandt, M. A. T., Ames, M. M., Schaid, D. J., & Wang, L. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0405 · Cited by 177 · see citing works
Self-citationFKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition
Baughman, G., Wiederrecht, G. J., Campbell, N. F., Martin, M. M., & Bourgeois, S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4395 · Cited by 173 · see citing works
Flagged first, then by citations
1 of the 27 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Collisson, E. A., Sadanandam, A., Olson, P., Gibb, W. J., Truitt, M., Gu, S., Cooc, J., Weinkle, J., Kim, G. E., Jakkula, L., et al. (2011) · Nature Medicine · doi:10.1038/nm.2344 · Cited by 1,967 · see citing works
Cysteine depletion induces pancreatic tumor ferroptosis in mice
Badgley, M. A., Kremer, D. M., Maurer, H. C., DelGiorno, K. E., Lee, H.-J., Purohit, V., Sagalovskiy, I. R., Ma, A., Kapilian, J., Firl, C. E. M., et al. (2020) · Science · doi:10.1126/science.aaw9872 · Cited by 1,294 · see citing works
Carver, B. S., Chapinski, C., Wongvipat, J., Hieronymus, H., Chen, Y., Chandarlapaty, S., Arora, V. K., Le, C. H., Koutcher, J. A., Scher, H. I., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.04.008 · Cited by 1,197 · see citing works
Gene–Stress–Epigenetic regulation of FKBP5: clinical and translational implications
Zannas, A. S., Wiechmann, T., Gassen, N. C., & Binder, E. B. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.235 · Cited by 622 · see citing works
Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer Growth
Mulholland, D. J., Tran, L. M., Li, Y., Cai, H., Morim, A., Wang, S., Plaisier, S. B., Garraway, I. P., Huang, J., Graeber, T. G., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.05.006 · Cited by 516 · see citing works
Davies, B. R., Greenwood, H., Dudley, P., Crafter, C., Yu, D.-H., Zhang, J., Li, J., Gao, B., Ji, Q., Maynard, J., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0824-t · Cited by 480 · see citing works
A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2
Yang, S., He, P., Wang, J., Schetter, A. J., Tang, W., Funamizu, N., Yanaga, K. K., Uwagawa, T., Satoskar, A. R., Gaedcke, J., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2841 · Cited by 393 · see citing works
Gassen, N. C., Niemeyer, D., Muth, D., Corman, V. M., Martinelli, S., Gassen, A., Hafner, K., Papies, J., Mösbauer, K., Zellner, A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13659-4 · Cited by 356 · see citing works
Zhang, W., Nandakumar, N., Shi, Y., Manzano, M., Smith, A., Graham, G., Gupta, S., Vietsch, E. E., Laughlin, S. Z., Wadhwa, M., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2005049 · Cited by 360 · see citing works
Liang, K., Liu, F., Fan, J., Sun, D., Liu, C., Lyon, C. J., Bernard, D. W., Li, Y., Yokoi, K., Katz, M. H. G., et al. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-016-0021 · Cited by 368 · see citing works
Rodríguez, E., Boelaars, K., Brown, K., Li, R. J. E., Kruijssen, L. J. W., Bruijns, S. C. M., van Ee, T., Schetters, S. T. T., Crommentuijn, M. H. W., van der Horst, J. C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21550-4 · Cited by 319 · see citing works
SIRT6 suppresses pancreatic cancer through control of Lin28b
Kugel, S., Sebastián, C., Fitamant, J., Ross, K., Saha, S., Jain, E., Gladden, A., Arora, K. S., Kato, Y., Rivera, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.033 · Cited by 251 · see citing works
Touma, C., Gassen, N. C., Herrmann, L., Cheung‐Flynn, J., Büll, D., Ionescu, I. A., Heinzmann, J.-M., Knapman, A., Siebertz, A., Depping, A., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.023 · Cited by 270 · see citing works
Martinelli, P., Pau, E. C. D. S., Cox, T. F., Sáinz, B., Dusetti, N., Greenhalf, W., Rinaldi, L., Costello, E., Ghaneh, P., Malats, N., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-311256 · Cited by 271 · see citing works
FKBP51 and FKBP52 in signaling and disease
Storer, C. L., Dickey, C. A., Galigniana, M. D., Rein, T., & Cox, M. B. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.08.001 · Cited by 266 · see citing works
“FKBP51 and FKBP52 probably have similar activity; however, unlike PIN1, the FKBPs probably coordinate with HSP90 to isomerize tau [49].”
Li, H., Wang, X., Wen, C., Huo, Z., Wang, W., Zhan, Q., Cheng, D., Chen, H., Deng, X., Peng, C., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0738-0 · Cited by 261 · see citing works
Protein kinase signaling networks in cancer
Brognard, J., & Hunter, T. R. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.012 · Cited by 241 · see citing works
Matosin, N., Halldorsdottir, T., & Binder, E. B. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.01.021 · Cited by 226 · see citing works
CRNDE: A Long Non-Coding RNA Involved in CanceR, Neurobiology, and DEvelopment
Ellis, B. C., Molloy, P. L., & Graham, L. D. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00270 · Cited by 228 · see citing works
Singh, S., Srivastava, S. K., Bhardwaj, A., Owen, L. B., & Singh, A. P. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605968 · Cited by 225 · see citing works
The dual role of autophagy in cancer
Eskelinen, E. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.03.009 · Cited by 222 · see citing works
Wu, M., Li, X., Zhang, T., Liu, Z., & Zhao, Y. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00996 · Cited by 218 · see citing works
Pungsrinont, T., Kallenbach, J., & Baniahmad, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011088 · Cited by 218 · see citing works
Kao, Y., Sung, Y., Zhang, L., Jungbluth, A. A., Huang, S., Argani, P., Agaram, N. P., Zin, A., Alaggio, R., & Antonescu, C. R. (2016) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000697 · Cited by 208 · see citing works
Jiang, S.-H., Zhu, L., Zhang, M., Li, R., Yang, Q., Yan, J., Zhang, C., Yang, J., Dong, F., Dai, M., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317479 · Cited by 197 · see citing works
Shang, Z., Yu, J., Sun, L., Tian, J., Zhu, S., Zhang, B., Dong, Q., Jiang, N., Flores‐Morales, A., Chang, C., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz108 · Cited by 191 · see citing works
Gassen, N. C., Hartmann, J., Zschocke, J., Stepan, J., Hafner, K., Zellner, A., Kirmeier, T., Kollmannsberger, L. K., Wagner, K. V., Dedic, N., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001755 · Cited by 177 · see citing works
HMGA2 as a Critical Regulator in Cancer Development
Mansoori, B., Mohammadi, A., Ditzel, H. J., Duijf, P. H. G., Khaze, V., Gjerstorff, M. F., & Baradaran, B. (2021) · Genes · doi:10.3390/genes12020269 · Cited by 201 · see citing works
Bauer, I., Grozio, A., Lasigliè, D., Basile, G., Sturla, L., Magnone, M., Sociali, G., Soncini, D., Caffa, I., Poggi, A. D., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.405837 · Cited by 176 · see citing works
In Vitro Human Cell Line Models to Predict Clinical Response to Anticancer Drugs
Niu, N., & Wang, L. (2015) · Pharmacogenomics · doi:10.2217/pgs.14.170 · Cited by 175 · see citing works
Self-citationFries, G. R., Gassen, N. C., & Rein, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122614 · Cited by 167 · see citing works
Plasma membrane V-ATPase controls oncogenic RAS-induced macropinocytosis
Ramírez, C., Hauser, A. D., Vucic, E., & Bar‐Sagi, D. (2019) · Nature · doi:10.1038/s41586-019-1831-x · Cited by 169 · see citing works
Regulation of Akt signaling activation by ubiquitination
Yang, W.-L., Wu, C.-Y., Wu, J., & Lin, H.-K. (2010) · Cell Cycle · doi:10.4161/cc.9.3.10508 · Cited by 164 · see citing works
AR Signaling and the PI3K Pathway in Prostate Cancer
Crumbaker, M., Khoja, L., & Joshua, A. M. (2017) · Cancers · doi:10.3390/cancers9040034 · Cited by 163 · see citing works
Down-weighting overlapping genes improves gene set analysis
Tarca, A. L., Drăghici, S., Bhatti, G., & Romero, R. J. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-136 · Cited by 154 · see citing works
Nagarajan, A. G., Dogra, S. K., Sun, L., Gandotra, N., Ho, T., Cai, G., Cline, G. W., Kumar, P., Cowles, R. A., & Wajapeyee, N. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.07.014 · Cited by 145 · see citing works
Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management
Scaroni, C., Zilio, M., Foti, M., & Boscaro, M. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1105 · Cited by 140 · see citing works
Large FK506-binding proteins shape the pharmacology of rapamycin
März, A. M., Fabian, A.-K., Kozany, C., Bracher, A., & Hausch, F. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00678-12 · Cited by 141 · see citing works
Zhou, M., Diao, Z., Yue, X., Yang, C., Zhao, H., Cheng, L., & Sun, J. (2016) · Oncotarget · doi:10.18632/oncotarget.10891 · Cited by 140 · see citing works
Posttranslational regulation of Akt in human cancer
Chan, C., Jo, U., Kohrman, A. Q., Rezaeian, A. H., Chou, P.-C., Logothetis, C. J., & Lin, H. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-59 · Cited by 139 · see citing works
Cholesterol accumulation in prostate cancer: A classic observation from a modern perspective
Krycer, J. R., & Brown, A. J. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.01.002 · Cited by 138 · see citing works
Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation
Müller, F., Lim, J. K. M., Bebber, C. M., Seidel, E., Tishina, S., Dahlhaus, A., Stroh, J., Beck, J., Yapici, F. I., Nakayama, K., et al. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-01096-8 · Cited by 140 · see citing works
DNA-PK Mediates AKT Activation and Apoptosis Inhibition in Clinically Acquired Platinum Resistance
Stronach, E. A., Chen, M. M., Maginn, E. N., Agarwal, R., Mills, G. B., Wasan, H. S., & Gabra, H. (2011) · Neoplasia · doi:10.1593/neo.111032 · Cited by 138 · see citing works
A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma
Haider, S., Wang, J., Nagano, A., Desai, A., Arumugam, P., Dumartin, L., Fitzgibbon, J., Hagemann, T., Marshall, J. F., Kocher, H. M., et al. (2014) · Genome Medicine · doi:10.1186/s13073-014-0105-3 · Cited by 138 · see citing works
Glucocorticoids, genes and brain function
Juszczak, G. R., & Stankiewicz, A. M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.11.020 · Cited by 135 · see citing works
Raho, S., Capobianco, L., Malivindi, R., Vozza, A., Piazzolla, C., Leonardis, F. D., Gorgoglione, R., Scarcia, P., Pezzuto, F., Agrimi, G., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00315-1 · Cited by 137 · see citing works
Teng, K., Mansour, A. G., Zhu, Z. G., Li, Z., Tian, L., Ma, S., Xu, B., Lu, T., Chen, H., Hou, D., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.12.281 · Cited by 136 · see citing works
High expression of CDK1 and BUB1 predicts poor prognosis of pancreatic ductal adenocarcinoma
Piao, J., Zhu, L., Sun, J. L., Li, N., Dong, B., Yang, Y., & Chen, L. (2019) · Gene · doi:10.1016/j.gene.2019.02.081 · Cited by 135 · see citing works
Stress-responsive FKBP51 regulates AKT2-AS160 signaling and metabolic function
Balsevich, G., Häusl, A. S., Meyer, C. W., Karamihalev, S., Feng, X., Pöhlmann, M. L., Dournes, C., Uribe-Marino, A., Santarelli, S., Labermaier, C., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01783-y · Cited by 134 · see citing works
Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer
Coothankandaswamy, V., Cao, S., Xu, Y., Prasad, P. D., Singh, P. K., Reynolds, C. P., Yang, S., Ogura, J., Ganapathy, V., & Bhutia, Y. D. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13616 · Cited by 132 · see citing works
Turning Off AKT: PHLPP as a Drug Target
Newton, A. C., & Trotman, L. C. (2014) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140338 · Cited by 131 · see citing works
Nuclear PI3K signaling in cell growth and tumorigenesis
Davis, W. J., Lehmann, P. Z., & Li, W. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00024 · Cited by 127 · see citing works
FK506-Binding Proteins and Their Diverse Functions
Tong, M., & Jiang, Y. (2015) · Current Molecular Pharmacology · doi:10.2174/1874467208666150519113541 · Cited by 126 · see citing works
Casein kinase 1α: biological mechanisms and theranostic potential
Jiang, S., Zhang, M., Sun, J., & Yang, X. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0236-z · Cited by 130 · see citing works
The role of FKBP5 in cancer aetiology and chemoresistance
Li, L., Lou, Z., & Wang, L. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6606014 · Cited by 129 · see citing works
Self-citationIdentification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma
Cheng, Y., Wang, K., Geng, L., Sun, J., Xu, W., Liu, D., Gong, S., & Zhu, Y. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.01.003 · Cited by 129 · see citing works
Colbert, L. E., Fisher, S. B., Hardy, C. W., Hall, W. A., Saka, B., Shelton, J. W., Petrova, A. V., Warren, M. D., Pantazides, B. G., Gandhi, K., et al. (2013) · Cancer · doi:10.1002/cncr.28144 · Cited by 126 · see citing works
Li, X.-J., Luo, X.-Q., Han, B.-W., Duan, F.-T., Wei, P.-P., & Chen, Y.-Q. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.562 · Cited by 126 · see citing works
Hähle, A., Merz, S., Meyners, C., & Hausch, F. (2019) · Biomolecules · doi:10.3390/biom9010035 · Cited by 119 · see citing works
Identifying dysregulated pathways in cancers from pathway interaction networks
Liu, K.-Q., Liu, Z.-P., Hao, J., Chen, L., & Zhao, X. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-126 · Cited by 123 · see citing works
Glucocorticoid receptor activates poised FKBP51 locus through long-distance interactions
Paakinaho, V., Makkonen, H., Jääskeläinen, T., & Palvimo, J. J. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0443 · Cited by 122 · see citing works
Maxfield, K., Taus, P., Corcoran, K., Wooten, J., Macion, J., Zhou, Y., Borromeo, M. D., Kollipara, R. K., Yan, J., Xie, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms9840 · Cited by 120 · see citing works
Li, A., Morton, J. P., Ma, Y., Karim, S. A., Zhou, Y., Faller, W. J., Woodham, E. F., Morris, H., Stevenson, R. P., Juin, A., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.046 · Cited by 114 · see citing works
Zhang, H., Li, X., Yang, Y., Zhang, Y., Wang, H., & Zheng, X. (2017) · Hepatology · doi:10.1002/hep.29715 · Cited by 115 · see citing works
CDA directs metabolism of epigenetic nucleosides revealing a therapeutic window in cancer
Zauri, M., Berridge, G., Thézénas, M., Pugh, K., Goldin, R. D., Kessler, B. M., & Kriaučionis, S. (2015) · Nature · doi:10.1038/nature14948 · Cited by 112 · see citing works
Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer
Candido, S., Maestro, R., Polesel, J., Catania, A., Maira, F., Signorelli, S. S., McCubrey, J. A., & Libra, M. (2014) · Oncotarget · doi:10.18632/oncotarget.1738 · Cited by 114 · see citing works
Lymphoblastoid Cell Lines in Pharmacogenomic Discovery and Clinical Translation
Wheeler, H. E., & Dolan, M. E. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.121 · Cited by 113 · see citing works
CHCHD2 inhibits apoptosis by interacting with Bcl-x L to regulate Bax activation
Liu, Y., Clegg, H. V., Leslie, P. L., Di, J., Tollini, L. A., He, Y. J., Kim, T.-H., Jin, A., Graves, L. M., Zheng, J., et al. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.194 · Cited by 111 · see citing works
Gassen, N. C., Fries, G. R., Zannas, A. S., Hartmann, J., Zschocke, J., Hafner, K., Carrillo‐Roa, T., Steinbacher, J., Preißinger, S. N., Hoeijmakers, L., et al. (2015) · Science Signaling · doi:10.1126/scisignal.aac7695 · Cited by 106 · see citing works
Logsdon, D. P., Grimard, M., Luo, M., Shahda, S., Jiang, Y., Tong, Y., Yu, Z., Zyromski, N. J., Schipani, E., Carta, F., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0253 · Cited by 108 · see citing works
Suppression of survival signalling pathways by the phosphatase PHLPP
O’Neill, A., Niederst, M. J., & Newton, A. C. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08537.x · Cited by 107 · see citing works
Sidibeh, C. O., Pereira, M. J., Abalo, X. M., Boersma, G. J., Skrtic, S., Lundkvist, P., Katsogiannos, P., Hausch, F., Castillejo-López, C., & Eriksson, J. W. (2018) · Endocrine · doi:10.1007/s12020-018-1674-5 · Cited by 102 · see citing works
Wei, X., Yang, J., Adair, S. J., Öztürk, H., Kuscu, C., Lee, K. Y., Kane, W. J., O’Hara, P. E., Liu, D., Demirlenk, Y. M., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009899117 · Cited by 107 · see citing works
Yang, S., Kim, C. Y., Hwang, S., Kim, E., Kim, H., Shim, H., & Lee, I. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw868 · Cited by 105 · see citing works
Multidomain Peptidyl Prolyl cis/trans Isomerases
Schiene‐Fischer, C. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.11.012 · Cited by 103 · see citing works
Regulation of Serine-Threonine Kinase Akt Activation by NAD+-Dependent Deacetylase SIRT7
Yu, J., Qin, B., Wu, F., Qin, S., Nowsheen, S., Shan, S., Zayas, J., Pei, H., Lou, Z., & Wang, L. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.009 · Cited by 104 · see citing works
Self-citationUSP49 negatively regulates tumorigenesis and chemoresistance through FKBP51‐AKT signaling
Luo, K., Li, Y., Yin, Y., Li, L., Wu, C., Chen, Y., Nowsheen, S., Hu, Q., Zhang, L., Lou, Z., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201695669 · Cited by 104 · see citing works
Self-citationAdipocytes promote ovarian cancer chemoresistance
Yang, J., Zaman, M. M., Vlasakov, I., Roy, R., Huang, L. J., Martin, C. R., Freedman, S. D., Serhan, C. N., & Moses, M. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-49649-1 · Cited by 104 · see citing works
Pancreatic cancer subtypes: a roadmap for precision medicine
Torres, C., & Grippo, P. J. (2018) · Annals of Medicine · doi:10.1080/07853890.2018.1453168 · Cited by 104 · see citing works
The acinar regulator Gata6 suppresses KrasG12V-driven pancreatic tumorigenesis in mice
Martinelli, P., Madriles, F., Cañamero, M., Pau, E., Pozo, N. D., Guerra, C., & Real, F. (2015) · Gut · doi:10.1136/gutjnl-2014-308042 · Cited by 95 · see citing works
Polman, J. A. E., Hunter, R. G., Speksnijder, N., van den Oever, J. M. E., Korobko, O. B., McEwen, B. S., de Kloet, E. R., & Datson, N. A. (2012) · Endocrinology · doi:10.1210/en.2012-1255 · Cited by 100 · see citing works
Pereira, M. J., Palming, J., Svensson, M. K. E., Rizell, M., Dalenbäck, J., Hammar, M., Fall, T., Sidibeh, C. O., Svensson, P., & Eriksson, J. W. (2014) · Metabolism · doi:10.1016/j.metabol.2014.05.015 · Cited by 101 · see citing works
The prospect of FKBP51 as a drug target
Schmidt, M. V., Paez‐Pereda, M., Holsboer, F., & Hausch, F. (2012) · ChemMedChem · doi:10.1002/cmdc.201200137 · Cited by 99 · see citing works
Cell Intrinsic Role of COX-2 in Pancreatic Cancer Development
Hill, R., Li, Y., Tran, L. M., Dry, S., Calvopina, J. H., Garcia, A. J., Kim, C. G., Wang, Y., Donahue, T. R., Herschman, H. R., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0342 · Cited by 99 · see citing works
Annett, S., Moore, G., & Robson, T. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107623 · Cited by 99 · see citing works
Ethno-veterinary uses of Poaceae in Punjab, Pakistan
Majeed, M., Bhatti, K. H., Amjad, M. S., Abbasi, A. M., Bussmann, R. W., Nawaz, F., Rashid, A., Mehmood, A., Mahmood, M., Khan, W. M., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241705 · Cited by 99 · see citing works
Meeusen, B., & Janssens, V. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.10.002 · Cited by 96 · see citing works
Chaperoning steroidal physiology: Lessons from mouse genetic models of Hsp90 and its cochaperones
Sánchez, E. R. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.11.006 · Cited by 96 · see citing works
Luo, L., McGarvey, P. B., Madhavan, S., Kumar, R., Gusev, Y., & Upadhyay, G. (2016) · Oncotarget · doi:10.18632/oncotarget.7163 · Cited by 96 · see citing works
Biological Actions of the Hsp90-binding Immunophilins FKBP51 and FKBP52
Zgajnar, N. R., Leo, S. A. D., Lotufo, C. M., Erlejman, A. G., Piwien‐Pilipuk, G., & Galigniana, M. D. (2019) · Biomolecules · doi:10.3390/biom9020052 · Cited by 94 · see citing works
Potent EMT and CSC Phenotypes Are Induced By Oncostatin-M in Pancreatic Cancer
Smigiel, J. M., Parameswaran, N., & Jackson, M. W. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0337 · Cited by 94 · see citing works
Peran, I., Dakshanamurthy, S., McCoy, M., Mavropoulos, A., Allo, B. A., Sebastian, A., Hum, N. R., Sprague, S. C., Martin, K. A., Pishvaian, M. J., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.11.044 · Cited by 93 · see citing works
Androgen deprivation–induced NCoA2 promotes metastatic and castration-resistant prostate cancer
Qin, J., Lee, H.-J., Wu, S., Lin, S., Lanz, R. B., Creighton, C. J., DeMayo, F. J., Tsai, S. Y., & Tsai, M. (2014) · Journal of Clinical Investigation · doi:10.1172/jci76412 · Cited by 92 · see citing works
BET Bromodomain Inhibitors Block Growth of Pancreatic Cancer Cells in Three-Dimensional Collagen
Sahai, V., Kumar, K., Knab, L. M., Chow, C. R., Raza, S. S., Bentrem, D. J., Ebine, K., & Munshi, H. G. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0925 · Cited by 93 · see citing works
Carbone, C., Moccia, T., Zhu, C., Paradiso, G., Budillon, A., Chiao, P. J., Abbruzzese, J. L., & Melisi, D. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1185 · Cited by 92 · see citing works
FKBP51 Null Mice Are Resistant to Diet-Induced Obesity and the PPARγ Agonist Rosiglitazone
Stechschulte, L. A., Qiu, B., Warrier, M., Hinds, T. D., Zhang, M., Gu, H., Xu, Y., Khuder, S. S., Russo, L., Najjar, S. M., et al. (2016) · Endocrinology · doi:10.1210/en.2015-1996 · Cited by 87 · see citing works
Six1 Promotes Proliferation of Pancreatic Cancer Cells via Upregulation of Cyclin D1 Expression
Li, Z., Tian, T., Lv, F., Chang, Y., Wang, X., Zhang, L., Li, X., Li, L., Ma, W., Wu, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059203 · Cited by 89 · see citing works
Self-citationComparative study on gene set and pathway topology-based enrichment methods
Bayerlová, M., Jung, K., Krämer, F., Klemm, F., Bleckmann, A., & Beißbarth, T. (2015) · BMC Bioinformatics · doi:10.1186/s12859-015-0751-5 · Cited by 88 · see citing works
Wang, Q., Chen, Z., Diao, X., & Huang, S. (2011) · Cancer Letters · doi:10.1016/j.canlet.2010.12.007 · Cited by 87 · see citing works
Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications
Fabbri, C., & Serretti, A. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0594-9 · Cited by 84 · see citing works
- Authors
- Pei, H., Li, L., Fridley, B. L., Jenkins, G. D., Kalari, K. R., Lingle, W., Petersen, G., Lou, Z., & Wang, L.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Lou, Zhenkun
- Wang, Liewei
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 16
- Issue
- 3
- Pages
- 259-266
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC2755578
- OpenAlex
- W1996667997
- Cited by
- 709
- References
- 27
- Citations by year
- 2026: 23 · 2025: 26 · 2024: 31 · 2023: 44 · 2022: 59 · 2021: 73 · 2020: 63 · 2019: 53 · 2018: 39 · 2017: 48 · 2016: 43 · 2015: 47 · 2014: 48 · 2013: 37 · 2012: 24
- FWCI
- 9.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA102701, P20CA102701, K22CA130828, P50CA102701, R01CA130996, R01CA129344, R01CA138461)
- National Institute of General Medical Sciences (U01GM061388, U19GM061388, GM61388)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- FKBP51, Akt, PHLPP, Akt dephosphorylation, scaffold proteins, pancreatic cancer, chemotherapy response, genotoxic stress, cell death
- MeSH terms
- Docetaxel, Tacrolimus Binding Protein 5, Antimetabolites, Antineoplastic, Antineoplastic Agents, Antineoplastic Agents, Phytogenic, Cell Line, Cytarabine, Drug Therapy, Humans, Kidney, Neoplasms, Nuclear Proteins, Pancreatic Neoplasms, Phosphoprotein Phosphatases, Paclitaxel, Tacrolimus Binding Proteins, Taxoids, Cell Line, Tumor, Proto-Oncogene Proteins c-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
